http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2015000787-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5be9456a74cc707cc9ad4370982a402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_904ec80c3a8ad4a1a00b4e787bd180de
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2015-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce11cd3655bc4113e9c83ab81aac9205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5460faf301b739634e5473b48a2f375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd899eb74c1522fe2582d040f43b5fe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23b0149d40a40ce40f96bf22f4b19a0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47ae8d000c307dc7ddaa9d70cd05df7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b095bd005b87d9121b6dbfb53415f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83b513da0dd0f51f5dd09e175af5ca9b
publicationDate 2015-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2015000787-A1
titleOfInvention 1,2,4-Triazine derivatives for the treatment of viral infections.
abstract COMPOUNDS DERIVED FROM 1,2,4-TRIAZINE; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND ITS USE FOR THE TREATMENT OF A DISORDER IN WHICH THE MODULATION OF TLR7 AND / OR TLR8 IS IMPLIED, SUCH AS VIRAL INFECTIONS AND IMMUNE OR INFLAMMATORY DISORDERS.
priorityDate 2012-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51284
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51311
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID684440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID317468
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID493686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67520
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID170744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574686
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID170743
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100534776

Total number of triples: 38.